MDPI World Antimicrobial Resistance Awareness Week Webinar 2024
the chair
In recognition of World Antimicrobial Resistance Awareness Week 2024 (https://www.who.int/campaigns/world-amr-awareness-week/2024), MDPI is organizing a special webinar aimed at bringing together researchers, clinicians, and public health experts to discuss the latest advancements in combating antimicrobial resistance (AMR), one of the most pressing challenges in global health today.
AMR is not only a public health crisis but also a socioeconomic issue, with wide-reaching negative effects on human and animal health, food security, and the environment. Drug-resistant pathogens pose a threat to everyone, everywhere. Despite this, there remains much to be done in terms of raising public and stakeholder awareness and promoting action against AMR.
Date: 22 November 2024
Time: 3:00 pm CET
Webinar ID: 882 6784 0911
Webinar Secretariat: journal.webinar@mdpi.com
Meet Our Speakers
Prof. Dr. Bojana Beović
Department of Infectious Diseases, University Medical Centre Ljubljana, Slovenia, Faculty of Medicine, University of Ljubljana, Slovenia;
Prof. Bojana Beović graduated from the Medical School at the University of Ljubljana, where she also earned her master’s degree and Ph.D. She completed her board certification in infectious diseases at the University Medical Centre (UMC) Ljubljana and pursued further training in pharmacology at the University of Zagreb and the University of Wisconsin Hospital and Clinics. A visiting professor in Trieste, Italy, she has been employed at the Department of Infectious Diseases at UMC Ljubljana since 1986, serving as an attending physician in the intensive care unit from 1993 to 2013. Currently, she leads the ID Consultancy Service and the Antimicrobial Stewardship Programme at UMC Ljubljana. Prof. Beović has held several leadership roles, including president of the Slovenian Society of Chemotherapy (2004–2018) and chair of the Intersectoral Coordination Mechanism for Prudent Use of Antimicrobials at the Ministry of Health since 2019. She has chaired the Antibiotic Committee at UMC Ljubljana since 2008 and has been actively involved with ESCMID, serving as honorary secretary and chair of the Study Group for Antimicrobial Stewardship and currently as co-chair of its Antimicrobial Stewardship Certificate Programme. During the COVID-19 pandemic, she led the Scientific Advisory Group to the Ministry of Health and is currently the president of the Medical Chamber of Slovenia. A full professor of infectious diseases at the University of Ljubljana, she has organized numerous scientific meetings and educational courses and is a frequently invited speaker at international events. Her primary research interests include antimicrobial stewardship and surgical infections, with over 350 publications to her name in national and international literature.
Prof. Dr. Paul Savage
Department of Chemistry and Biochemistry, Brigham Young University, USA;
Paul B. Savage is the Reed M. Izatt Professor of Chemistry and Biochemistry at Brigham Young University. He received his undergraduate degree at BYU and his PhD at the University of Wisconsin. He did postdoctoral research at the Ohio State University. His interests encompass chemical biology, which emphases in development of non-peptide mimics of antimicrobial peptides, natural killer T cell adjuvants, conjugate carbohydrate vaccines and high-affinity antibodies against bacterial polysaccharides.
Prof. Dr. Raymond J. Turner
Department of Biological Sciences, University of Calgary, Canada;
Raymond J. Turner is a multi-ethnic, multi-generational Canadian and Faculty Professor of Science at the University of Calgary, where he has also held roles as Department Head, Graduate Program Director, and Director of the Biofilm Research Group. With a B.Sc. in Biochemistry and a Ph.D. in Biophysical Chemistry, followed by postdoctoral training in Clinical Microbiology and Molecular Biochemistry, he has garnered research funding from NSERC, CIHR, Genome Canada, MITACS, and industrial partners. Recognized with awards for research and graduate supervision, he also holds multiple Faculty Fellowships from the Institute of Advanced Studies in Italy, fostering international collaborations. His research as a Microbial Biochemist spans antimicrobial resistance, bioremediation, bioinorganic chemistry, and nanotechnology, focusing on bacterial resistance mechanisms to stressors such as metals and pollutants, with applications in bioremediation, green nanomaterial synthesis, and antimicrobial development. Additionally, he teaches courses on biomembranes, toxicology, and biofilms and contributes to Canada’s AMR One Health Consortium, delivering insights on resistance mechanisms through the AMR: A One Health Approach Seminar Series.
Prof. Dr. Albert Figueras
Independent consultant on Pharmacovigilance, Rational Medicines Utilization and Antimicrobial Use.Barcelona, Spain;
Albert Figueras is a Medical Doctor and Clinical Pharmacologist by training and retired Professor of Pharmacology at the Universitat Autònoma de Barcelona, he has over 20 years of experience consulting for organizations such as WHO, the World Bank, the Asian Development Bank, and the Africa CDC. His work in research, training, and consultancy has taken him to over 55 countries across Latin America, Africa, Asia, and Europe, and he has published more than 100 articles in peer-reviewed journals. In addition to serving as a reviewer for journals like MDPI, JAMA, BMJ, The Lancet, and the European Journal of Clinical Pharmacology, he is an Academic Editor for MDPI’s Antibiotics.
Prof. Dr. Hanne Ingmer
Department of Veterinary and Animal Science, University of Copenhagen, Denmark;
I am trained as chemical engineer and have always had a passion for microbiology. After doing a PhD in Denmark I was post doc at Stanford University where I worked with plasmids expressing antibiotic resistance genes. In 2004 I became a professor at University of Copenhagen and since then, I have worked with the human pathogen, Staphylococcus aureus focusing on how it both can be a harmless colonizer of humans as well as an aggressive pathogen. Currently my research has three cornerstones namely development of antibiotic resistance, quorum sensing communication as a target for anti-virulence therapy and phages as potential solutions to the antibiotic resistance crisis.
Dr. Manuel Simões
LEPABE-Department of Chemical and Biological Engineering, Faculty of Engineering, University of Porto, Portugal;
Manuel Simões is an Associate Professor with Habilitation at the Department of Chemical Engineering - Faculty of Engineering – University of Porto and a senior researcher at LEPABE-ALiCE research centre. His main research interests involve the development of microbial control strategies, particularly biofilms, using innovative molecules. Since 2020 he is one of the 1% most cited researchers worldwide.
The webinar was hosted via Zoom and required registration to attend. The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking “Subscribe” at the top of the page.
Antibiotics
Knowledge, Attitudes and Practices of Antimicrobial Resistance and Stewardship in Primary Care Setting: From Understanding to Informing Interventions
Edited by Amanj Kurdi
Deadline for manuscript submissions: 31 March 2025
Viruses
Herpesviruses and Associated Diseases
Edited by Sherif T. S. Hassan
Deadline for manuscript submissions: 31 July 2025
Structure-Based Antiviral Drugs and Vaccine Design
Edited by Shi-hua Xiang and Fengwei Bai
Deadline for manuscript submissions: 30 April 2025
Pharmaceuticals
New Approaches to Fighting Infectious Diseases: Overcoming the Antimicrobial Resistance in Current Treatments
Edited by Antonia Efstathiou and Dimitra K. Toubanaki
Deadline for manuscript submissions: 20 February 2025
CIMB
Bioinformatics Research in Bacterial Genomics, Metagenomics and Metatranscriptomics
Edited by Vesselin Baev
Deadline for manuscript submissions: 31 January 2025
Healthcare
Advances in Pharmacy Practice and Medication Use among Patients
Edited by Anna Puścion-Jakubik
Deadline for manuscript submissions: 30 June 2025
Microorganisms
Clinical Microbial Infection and Antimicrobial Resistance
Edited by Louis Saravolatz
Deadline for manuscript submissions: 31 March 2025
Microbiology Research
Antileishmanial Agents
Edited by Edson Roberto da Silva
Deadline for manuscript submissions: 28 February 2025